Economic evaluation of human urinary kallindinogenase for patients with acute ischemic stroke in China.
CONCLUSION: This economic evaluation study indicates that administrating HUK is a cost-saving therapy compared with NBP for managing blood flow during AIS in Chinese setting.
PMID: 29706099 [PubMed - as supplied by publisher]
Source: Journal of Medical Economics - Category: Health Management Tags: J Med Econ Source Type: research
More News: China Health | Economics | Health Management | Ischemic Stroke | Sports Medicine | Statistics | Stroke | Study